RETATRUTIDE 20MG PEN

Triple-Hormone Synergy for Advanced Weight
Management Research

Product Overview

Retatrutide is an innovative triple hormone receptor agonist that concurrently activates GLP-1, GIP, and glucagon receptors. This complex mechanism presents exceptional possibilities in the fields of weight loss and metabolic health research. The 20mg vial offers a more economical choice for prolonged research protocols.

* Key Advantages

Triple Hormone Activation: Stimulates GLP-1, GIP, and glucagon receptors to work together for improved weight loss and metabolic control.
Superior Weight Loss: Research has shown a body weight reduction of up to 24.2% over 48 weeks with a 12 mg dosage, outperforming other treatments such as Ozempic and Mounjaro.
Improved Metabolic Health: Notable enhancements in liver fat levels and cardiometabolic indicators, suggesting wider health benefits.
Cost-Effectiveness: Acquiring the 20mg vial lowers the cost per milligram compared to the 10mg alternative, providing greater value for long-term research requirements.

Composition

Active Ingredient: Retatrutide
Concentration: 20mg per vial
Form: Lyophilized peptide powder
Usage & Storage

Intended Use: For research purposes exclusively

Storage: Keep the lyophilized powder in a cool, dry environment.
After reconstitution, store in the refrigerator at 2-8°C and utilize within the specified study timeframe.